EFG Asset Management North America Corp. Has $1.58 Million Holdings in IQVIA Holdings Inc. $IQV

EFG Asset Management North America Corp. decreased its stake in IQVIA Holdings Inc. (NYSE:IQV) by 3.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,057 shares of the medical research company’s stock after selling 411 shares during the quarter. EFG Asset Management North America Corp.’s holdings in IQVIA were worth $1,584,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of IQV. Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of IQVIA by 436.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 161 shares of the medical research company’s stock valued at $28,000 after purchasing an additional 131 shares in the last quarter. AllSquare Wealth Management LLC acquired a new position in IQVIA in the first quarter valued at about $33,000. Trust Co. of Toledo NA OH acquired a new position in IQVIA in the second quarter valued at about $39,000. J.Safra Asset Management Corp increased its holdings in shares of IQVIA by 208.6% during the second quarter. J.Safra Asset Management Corp now owns 250 shares of the medical research company’s stock worth $39,000 after buying an additional 169 shares in the last quarter. Finally, NewSquare Capital LLC raised its stake in shares of IQVIA by 185.3% in the second quarter. NewSquare Capital LLC now owns 291 shares of the medical research company’s stock valued at $46,000 after acquiring an additional 189 shares during the last quarter. 89.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on IQV shares. Baird R W upgraded IQVIA from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, October 29th. Redburn Partners set a $214.00 target price on IQVIA in a research note on Wednesday, September 3rd. William Blair reiterated an “outperform” rating on shares of IQVIA in a research report on Wednesday, July 23rd. TD Cowen cut shares of IQVIA from a “buy” rating to a “hold” rating and raised their price objective for the company from $206.00 to $215.00 in a research report on Monday. Finally, Mizuho boosted their target price on shares of IQVIA from $190.00 to $225.00 and gave the stock an “outperform” rating in a research note on Friday, July 25th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, IQVIA currently has an average rating of “Moderate Buy” and an average target price of $239.94.

IQVIA Stock Performance

Shares of NYSE:IQV opened at $210.19 on Thursday. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 2.03. IQVIA Holdings Inc. has a 1-year low of $134.65 and a 1-year high of $225.91. The stock has a market capitalization of $35.80 billion, a P/E ratio of 28.83, a P/E/G ratio of 2.36 and a beta of 1.34. The business has a 50-day moving average price of $198.53 and a two-hundred day moving average price of $175.34.

IQVIA (NYSE:IQV) last issued its quarterly earnings results on Tuesday, October 28th. The medical research company reported $3.00 EPS for the quarter, topping the consensus estimate of $2.98 by $0.02. The company had revenue of $4.10 billion during the quarter, compared to analysts’ expectations of $4.07 billion. IQVIA had a net margin of 8.07% and a return on equity of 30.70%. IQVIA’s revenue was up 5.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.84 EPS. IQVIA has set its FY 2025 guidance at 11.850-11.950 EPS. Equities analysts predict that IQVIA Holdings Inc. will post 10.84 earnings per share for the current year.

Insider Activity at IQVIA

In other news, insider Eric Sherbet sold 4,000 shares of the stock in a transaction on Wednesday, October 29th. The stock was sold at an average price of $219.70, for a total value of $878,800.00. Following the transaction, the insider owned 27,108 shares of the company’s stock, valued at $5,955,627.60. This represents a 12.86% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 1.60% of the company’s stock.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.